1. Home
  2. RAYA vs SCNI Comparison

RAYA vs SCNI Comparison

Compare RAYA & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Erayak Power Solution Group Inc.

RAYA

Erayak Power Solution Group Inc.

HOLD

Current Price

$0.46

Market Cap

2.5M

ML Signal

HOLD

SCNI

Scinai Immunotherapeutics Ltd.

HOLD

Current Price

$0.56

Market Cap

2.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAYA
SCNI
Founded
2019
2003
Country
China
Israel
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5M
2.3M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
RAYA
SCNI
Price
$0.46
$0.56
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
16.2M
30.0K
Earning Date
04-17-2026
04-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.00
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$20.95
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.03
$0.55
52 Week High
$10.14
$6.18

Technical Indicators

Market Signals
Indicator
RAYA
SCNI
Relative Strength Index (RSI) 41.97 34.83
Support Level $0.04 $0.55
Resistance Level $1.02 $0.71
Average True Range (ATR) 0.08 0.05
MACD 0.03 0.01
Stochastic Oscillator 15.86 8.44

Price Performance

Historical Comparison
RAYA
SCNI

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Share on Social Networks: